本页面由Tiger Trade Technology Pte. Ltd.提供服务

Royalty Pharma plc

57.78
+0.85001.49%
盘前:56.50-1.2800-2.22%07:20 EDT
成交量:246.53万
成交额:1.42亿
市值:333.35亿
市盈率:30.99
高:57.92
开:57.04
低:56.85
收:56.93
52周最高:64.38
52周最低:35.50
股本:5.77亿
流通股本:3.93亿
量比:0.78
换手率:0.63%
股息:0.91
股息率:1.58%
每股收益(TTM):1.86
每股收益(LYR):1.78
净资产收益率:13.97%
总资产收益率:5.09%
市净率:4.88
市盈率(LYR):32.44

数据加载中...

2026/05/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/04/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/13

重要事件披露

Form 8-K - Current report
2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/11

重要事件披露

Form 8-K - Current report
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/22

重要事件披露

Form 8-K - Current report